Biocompatibility of Polymers

In simpler terms, a biocompatible material can interact with a biological system without causing harm or triggering adverse reactions. This interaction can range from simple contact to implantation within the body. An overview of this framework is shown in Figure 1.  

 

Figure 1: The Essential Biocompatibility Paradigm1
 

The figure above shows the generic pathway in biocompatibility starts with initial contact from which arises one or more causative events. The host response progresses with variable kinetics and significance, leading either to a clinically acceptable resolution or an unacceptable clinical outcome¹. 


 

Characteristics of biocompatible materials

For a polymer to act like an effective biocompatible material, it should exhibit the following characteristics:

 

Factors influencing biocompatibility of a polymer

1. Chemical composition:

   The chemical composition of biocompatible materials is fundamental to their performance and safety.
    

   • Additives play a crucial role in enhancing material properties, including processing aids for manufacturing efficiency, stabilizers to prevent degradation, and plasticizers for flexibility.
   • Fillers, such as glass fibers and minerals, are incorporated to improve mechanical strength and reduce costs while maintaining biocompatibility.
   • The presence of residual monomers from the manufacturing process must be carefully controlled, as these unreacted materials can potentially leach into surrounding tissues and affect long-term stability and safety.

2. Surface properties:

   Surface characteristics are critical determinants of how materials interact with biological systems.
    

   • Surface roughness at the microscopic level influences cell adhesion, protein adsorption, and bacterial colonization patterns.
   • Surface energy properties determine wettability and cell attachment behavior, directly impacting blood compatibility and tissue response.
   • The topographical features, including micro and nano-scale patterns, significantly affect tissue integration and healing responses, making surface properties a crucial consideration in biocompatible material design.

3. Manufacturing processes:

   Manufacturing methods significantly impact the final biocompatibility of materials.
    

   • Injection molding processes must carefully control temperature and pressure to prevent residual stress formation and ensure optimal surface finish.
   • Extrusion techniques affect material orientation and surface characteristics through die design and processing conditions.
   • Sterilization methods, whether using ethylene oxide, gamma radiation, or steam, can modify material properties and surface characteristics, potentially affecting biocompatibility through chemical residuals or degradation effects.

4. Environmental factors:

   Environmental conditions play a vital role in maintaining biocompatibility throughout a product's lifecycle. 
    

   • Temperature variations during storage and use can affect material stability and performance, potentially leading to thermal degradation or property changes.
   • Humidity levels influence moisture absorption and material swelling, which can alter properties and degradation rates.
   • The duration of exposure to these environmental conditions, whether short-term or long-term, cumulative impacts on material aging, and degradation patterns must be carefully considered to ensure sustained biocompatibility throughout the intended use period.

Here's an overview of some common biocompatible polymers used in the plastics industry:

 

1. Polyethylene (PE): It is a widely used biocompatible polymer. Commonly found in medical devices, prosthetics, and packaging for healthcare products. PE has good chemical resistance, impact strength, and can be sterilized. Select 10+ biocompatible polyethylene grades here.

2. Polypropylene (PP): Polypropylene is another versatile biocompatible polymer. Used in a variety of medical applications such as syringes, IV components, and sutures. PP has high thermal resistance, good mechanical properties, and can be sterilized. Select 20+ biocompatible polypropylene grades here

3. Polytetrafluoroethylene (PTFE): Also known as Teflon, PTFE is a biocompatible polymer with excellent chemical and thermal resistance. It is commonly used in medical implants, catheters, and other devices due to its non-stick and anti-fouling properties. Select 15+ biocompatible PTFE grades here.

4. Polylactic Acid (PLA): PLA is a biodegradable and biocompatible polymer derived from renewable resources like corn starch or sugarcane. It is used in tissue engineering scaffolds, sutures, drug delivery systems, and compostable packaging. Select biocompatible PLA grades here.

5. Polyurethane (PU): A family of biocompatible polymers with a wide range of mechanical and physical properties. They are used in medical devices, implants, wound dressings, and other healthcare applications. Select 80+ biocompatible polyurethane grades here.

6. Silicone rubbers: They are biocompatible, inert, and widely used in medical devices such as implants, catheters, and tubing. They are valued for their flexibility, durability, and resistance to degradation. Select 35+ biocompatible silicone rubbers here.

Select from over 980+ biocompatible polymers available in our database.

 

The specific tests required depend on the intended use of the material or device, its duration of contact with the body, and the type of tissue it will interact with. Both in vitro and in vivo investigations of biocompatibility are chosen to evaluate the safety of the final product. To optimally standardize appropriate test choices, medical devices were categorized according to the duration and the level of tissue contact (from surface contact to implantation) (Figure 2).

 

Figure 2: Decision Tree According to Short/Long Term Medical Device Use³

In vitro tests

In vitro models typically involve specific biological components, such as cells, tissues, or biological molecules isolated from an organism. In vitro experiments enable precise manipulation and isolation of variables, facilitating detailed mechanistic studies such as cellular or molecular processes.

In vitro testing is preferred when studying cellular or molecular processes through various types of cells in culture. Most molecular and biochemical assays are conducted in vitro in the labs for testing purposes.

Cell-culture based techniques employed for biological evaluation aim to investigate the biological responses at a cellular level in models that simulate, as possible, the in vivo environment. These techniques serve also in some cases to evaluate the functional performance of the studied biomaterials (Figure 3).

 

Figure 3: In Vitro Tests for Biocompatibility Assessment and Conventional Cell Model Choice³

Cytotoxicity tests

Cytotoxicity is a measure of a substance's ability to kill cells. In the context of biocompatibility, it assesses a polymer's potential to harm living cells. Several methods are employed to evaluate cytotoxicity:

 

• Direct Contact Test: Polymer samples are directly placed in contact with cell cultures. Cell viability and morphology are assessed microscopically. This method provides a direct assessment of the polymer's impact on cells.
• Indirect Contact Test: The polymer is extracted in a suitable solvent, and the extract is then added to cell cultures. This method helps evaluate the potential toxicity of leachable substances from the polymer.
• Agar Diffusion Test: A polymer sample is placed on an agar plate inoculated with cells. If the polymer is cytotoxic, a zone of cell inhibition will form around the sample.
• Neutral Red Uptake Assay: This colorimetric assay measures the ability of cells to take up neutral red dye. Reduced dye uptake indicates cell damage or death.

Methods to evaluate in vitro tests

Mentioned below is a list of in vitro tests along with their desired test methods used by the manufacturer while evaluating biocompatibility.

 

In vivo tests

In vivo tests evaluate the biocompatibility of plastics in living organisms, typically animals. These tests assess the material's potential to cause adverse biological responses.

 

Tests for Systemic Toxicity

• Acute Systemic Toxicity: This test evaluates the systemic toxicity of a material or device after a single exposure. It assesses the potential for acute adverse effects, such as organ damage or death.
• Subacute Toxicity: This test assesses the effects of repeated exposure to a material or device over a short period. It helps identify potential subacute toxicity, such as organ damage or functional impairment.
• Subchronic Toxicity: This test evaluates the effects of repeated exposure to a material or device over a longer period. It helps identify potential chronic toxicity, such as cancer or reproductive toxicity.

Methods to evaluate in vivo tests

Mentioned below is a list of in vivo tests along with their desired test methods used by the manufacturer while evaluating biocompatibility.

 

The biocompatibility evaluation of medical devices and implantable drug delivery systems is a multi-stage approach. It begins with the initial screening of new materials, non-clinical and clinical pre-market safety evaluations, product release testing, and product periodic audits. This sequence allows the concerned products to meet current standards. Biological evaluation of medical devices is regulated by internationally recognized standards including: 

 

International standards

1. ISO-10993 guidelines are intended to help manufacturers address device biocompatibility requirements². Part 1 of the norm outlines the rational of tests selection, Part 2 details animal well-being recommendations, and parts 3 through 20 concern specific aspects of biocompatibility test procedures or specific materials test procedures.⁴ ISO framework for assessing the biocompatibility of medical devices include:
   
    

   Part 1: Evaluation and Testing Part 2: Animal Well-being Recommendations Part 3: Genotoxicity, Carcinogenicity, and Reproductive Toxicity Part 4: Selection of Tests for Interactions with Blood Part 5: Tests for In Vitro Cytotoxicity Part 6: Tests for Local Effects after Implantation Part 10: Tests for Irritation and Skin Sensitization Part 11: Tests for Systemic Toxicity

   Part 12: Sample Preparation and Reference Materials Part 13: Identification and Quantification of Degradation Products Part 14: Identification and Quantification of Products from Materials Part 16: Toxicokinetic Study Design for Degradation Products Part 17: Establishment of Allowable Limits for Leachable Substances Part 18: Chemical Characterization of Materials Part 19: Physicochemical, Morphological, and Topographical Characterization Part 20: Immunotoxicity Testing

    

    

   Biological studies performed according to ISO 10993 recommendations are acceptable in Europe and most of Asian countries. The FDA has accepted the ISO guideline but has more strict requirements in some specific areas.

1. ISO 14630: Non-Clinical Safety Testing for Biological Compatibility
   Scope: This International Standard specifies requirements for non-clinical safety testing of medical devices to assess their biological compatibility.

2. ISO 13485: Medical Devices - Quality Management Systems
   Scope: Outlines requirements for a quality management system (QMS) for medical device manufacturers. It ensures organizations design, develop, produce, and distribute medical devices that meet regulatory requirements and customer expectations.

American standards

1. ASTM F1983: This standard specifies requirements for evaluating biocompatibility of medical devices.

2. ASTM F2150: This guide provides a framework for evaluating biological adverse effects of medical devices.

3. ASTM F763: This standard practice provides a screening method for evaluating the biocompatibility of implant materials using short-term in vitro and in vivo tests.

4. USP <87> : Evaluates the biological reactivity of materials using in vitro tests. Applies to materials used in medical devices, pharmaceutical packaging, and other healthcare applications.

5. USP <88>: Evaluates the biological reactivity of materials using in vivo tests. Applies to materials used in medical devices, pharmaceutical packaging, and other healthcare applications.

6. USP VI Class: The United States Pharmacopeia (USP) VI Class refers to a classification system for plastics used in medical devices, pharmaceutical packaging, and other healthcare applications. To meet USP VI Class requirements, materials must pass biological reactivity tests, ensuring they are non-toxic and non-reactive.

7. FDA Guidance: Biocompatibility Evaluation of Medical Devices. Applies to all medical devices that contact the body. Ensures medical devices are safe and effective. Select 220+ FDA-compliant biocompatible polymers here.

8. 21 CFR 801: Labeling Requirements for Medical Devices. Applies to all medical devices. Ensures accurate and clear information for healthcare professionals and patients.

9. 21 CFR 812: Investigational Device Exemptions. Applies to investigational medical devices. Ensures safe and controlled clinical investigations of medical devices.

European regulatory standards

1. EU MDR (2017/745): Medical Device Regulation. Ensures medical devices sold in the EU meet safety, performance, and quality standards. Applies to medical devices, including implantable devices, active implantable devices, invasive and non-invasive devices.

2. EU IVDR (2017/746): In Vitro Diagnostic Medical Device Regulation. Ensures in vitro diagnostic medical devices (IVDs) sold in the EU meet safety, performance, and quality standards. Applies to IVDs, including laboratory tests, point-of-care testing devices, self-testing devices and companion diagnostics.
   
    

Biocompatible polymers have revolutionized the field of medicine and healthcare. Their versatility, biocompatibility, and customizable properties have led to a wide range of applications. Here are some of the key areas where polymer biocompatible polymers are used⁵:   


 

Medical sector

1. Polymer-based implants: These include artificial joints, heart valves, and dental implants, are designed to replace or repair damaged tissues.
2. Catheters and Tubes: Flexible and biocompatible polymers are used for minimally invasive procedures.
3. Contact Lenses: Soft, biocompatible polymers are used to create comfortable and durable contact lenses.  
4. Surgical Sutures: Biodegradable polymer sutures dissolve over time, eliminating the need for suture removal.  

Select 870+ biocompatible polymers used in the medical industry »



 

Biotechnology

1. Scaffolds: Polymer scaffolds provide a 3D structure for cells to grow and differentiate into new tissues, aiding in tissue regeneration and repair.
2. Wound Dressings: Biodegradable polymer dressings promote wound healing by creating a moist environment.
3. Controlled Release: Polymers can be designed to release drugs at a specific rate, prolonging therapeutic effects.
4. Targeted Drug Delivery: Polymer-based carriers can target specific tissues or cells, increasing drug efficacy.
5. Biosensors: Polymer-based biosensors can detect various biological molecules, such as glucose, proteins, and DNA.  

Packaging industry

1. Food packaging: Biodegradable trays, containers, films, bags forks, knives, and spoons (e.g., PLA, PBAT, and PHA).
2. Pharmaceutical packaging: Bottles, caps, and blister packs (e.g., HDPE, PET, and PVC).
3. Medical device packaging: Sterilizable packaging for medical instruments (e.g., PET, PVC, and PE).
4. Personal care products: Biodegradable toothbrushes, hair combs, and makeup brushes (e.g., PLA, PHA).
5. 3D printing materials: Biocompatible filaments for medical models and implants (e.g., PLA, PCL).

Select 100+ biocompatible polymers used in the packaging industry »



 

Automotive industry

1. Interior components: Biocompatible polyurethane (PU) and polyethylene (PE) are used in dashboards, door panels, and seat trim.
2. Biodegradable plastics: Biocompatible polylactic acid (PLA) and polyhydroxyalkanoates (PHA) are used in interior parts, such as trim and insulation.
3. Wire and cable insulation: Biocompatible polyethylene (PE) and polypropylene (PP) replace traditional PVC.
4. Fuel systems: Biocompatible fluoropolymers like PVDF and PTFE are used in fuel lines and components.

Select 15+ biocompatible polymers used in the automotive industry »


 

Electronics industry

1. Printed circuit boards (PCBs): Polyimide (PI) and polyetherimide (PEI) replace traditional FR4 materials.
2. Connectors and sockets: Polyphenylsulfone (PPSU) and polyetheretherketone (PEEK) ensure reliable connections.
3. Cable insulation: Cross-linked polyethylene (XLPE) and ethylene propylene rubber (EPR) replace traditional PVC.
4. Display components: Polycarbonate (PC) and polyethylene terephthalate (PET) enhance display durability.
5. Sustainable electronics: Biodegradable polymers like PLA and PHA enable compostable electronics.

Select 25+ biocompatible polymers used in the electronics industry »



 

Electrical industry

1. Insulation materials: Biocompatible polymers like XLPE and EPR replace traditional PVC.
2. Cable jackets: Biocompatible polymers like PE and PP ensure durability and flame resistance.
3. Connectors and switches: Biocompatible polymers like PPSU and PEEK ensure reliable connections.
4. Enclosures and housings: Biocompatible polymers like PC and ABS enhance durability.
5. Smart grid components: Biocompatible polymers like polyvinylidene fluoride (PVDF) enable efficient energy transmission.

Select 70+ biocompatible polymers used in the electrical industry »


 

The future of biocompatible polymers is promising. Ongoing research and development leads to innovative applications in healthcare and beyond. As technology advances, we can expect to see even more innovative uses of biocompatible plastics in the years to come.